PubRank

C Peters

Author PubWeight™ 227.25‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Cathepsin L: critical role in Ii degradation and CD4 T cell selection in the thymus. Science 1998 3.98
2 Genome-wide, large-scale production of mutant mice by ENU mutagenesis. Nat Genet 2000 3.92
3 Cathepsin B contributes to TNF-alpha-mediated hepatocyte apoptosis by promoting mitochondrial release of cytochrome c. J Clin Invest 2000 3.58
4 Role of cathepsin B in intracellular trypsinogen activation and the onset of acute pancreatitis. J Clin Invest 2000 3.47
5 Comparison of outcomes of unrelated bone marrow and umbilical cord blood transplants in children with acute leukemia. Blood 2001 2.99
6 Noggin is a mesenchymally derived stimulator of hair-follicle induction. Nat Cell Biol 1999 2.99
7 The interleukin (IL) 2 receptor beta chain is shared by IL-2 and a cytokine, provisionally designated IL-T, that stimulates T-cell proliferation and the induction of lymphokine-activated killer cells. Proc Natl Acad Sci U S A 1994 2.79
8 Cathepsins B and D are dispensable for major histocompatibility complex class II-mediated antigen presentation. Proc Natl Acad Sci U S A 1998 2.75
9 A lymphokine, provisionally designated interleukin T and produced by a human adult T-cell leukemia line, stimulates T-cell proliferation and the induction of lymphokine-activated killer cells. Proc Natl Acad Sci U S A 1994 2.51
10 Transmission of Ebola virus (Zaire strain) to uninfected control monkeys in a biocontainment laboratory. Lancet 1996 2.45
11 Cathepsin D deficiency induces lysosomal storage with ceroid lipofuscin in mouse CNS neurons. J Neurosci 2000 2.21
12 The overactive bladder in childhood: long-term results with conservative management. J Urol 2000 2.14
13 Two Listeria monocytogenes vaccine vectors that express different molecular forms of human papilloma virus-16 (HPV-16) E7 induce qualitatively different T cell immunity that correlates with their ability to induce regression of established tumors immortalized by HPV-16. J Immunol 2001 2.13
14 Cathepsin L deficiency as molecular defect of furless: hyperproliferation of keratinocytes and pertubation of hair follicle cycling. FASEB J 2000 2.09
15 Allogeneic and autologous transplantation for haematological diseases, solid tumours and immune disorders: current practice in Europe 2009. Bone Marrow Transplant 2009 2.00
16 Long-term effect of bone-marrow transplantation for childhood-onset cerebral X-linked adrenoleukodystrophy. Lancet 2000 1.98
17 The EBMT activity survey: 1990-2010. Bone Marrow Transplant 2012 1.96
18 Defibrotide in the treatment of children with veno-occlusive disease (VOD): a retrospective multicentre study demonstrates therapeutic efficacy upon early intervention. Bone Marrow Transplant 2004 1.84
19 Wolman disease successfully treated by bone marrow transplantation. Bone Marrow Transplant 2000 1.75
20 The essential tyrosine of the internalization signal in lysosomal acid phosphatase is part of a beta turn. Cell 1991 1.72
21 Bone marrow transplantation for globoid cell leukodystrophy, adrenoleukodystrophy, metachromatic leukodystrophy, and Hurler syndrome. Curr Opin Hematol 1999 1.59
22 The cytoplasmic tail of lysosomal acid phosphatase contains overlapping but distinct signals for basolateral sorting and rapid internalization in polarized MDCK cells. EMBO J 1993 1.57
23 Cathepsin D targeted by acid sphingomyelinase-derived ceramide. EMBO J 1999 1.56
24 Bone marrow-derived mesenchymal stem cells remain host-derived despite successful hematopoietic engraftment after allogeneic transplantation in patients with lysosomal and peroxisomal storage diseases. Exp Hematol 1999 1.55
25 Proteases involved in MHC class II antigen presentation. Immunol Rev 1999 1.54
26 Atmospheric detection of water dimers via near-infrared absorption. Science 2003 1.52
27 Bone marrow transplantation as effective treatment of central nervous system disease in globoid cell leukodystrophy, metachromatic leukodystrophy, adrenoleukodystrophy, mannosidosis, fucosidosis, aspartylglucosaminuria, Hurler, Maroteaux-Lamy, and Sly syndromes, and Gaucher disease type III. Curr Opin Neurol 1999 1.49
28 Functional expression of human cathepsin S in Saccharomyces cerevisiae. Purification and characterization of the recombinant enzyme. J Biol Chem 1993 1.49
29 Hematopoietic stem-cell transplantation in globoid-cell leukodystrophy. N Engl J Med 1998 1.47
30 Allogeneic bone marrow stem cell transplantation following CD34+ immunomagnetic enrichment in patients with inherited metabolic storage diseases. Bone Marrow Transplant 2003 1.47
31 Haematopoietic SCT in severe autoimmune diseases: updated guidelines of the European Group for Blood and Marrow Transplantation. Bone Marrow Transplant 2011 1.46
32 Phenotype of arylsulfatase A-deficient mice: relationship to human metachromatic leukodystrophy. Proc Natl Acad Sci U S A 1996 1.44
33 Reduced tumour cell proliferation and delayed development of high-grade mammary carcinomas in cathepsin B-deficient mice. Oncogene 2008 1.40
34 Capillary leak syndrome during low dose granulocyte-macrophage colony-stimulating factor (rh GM-CSF) treatment of a patient in a continuous febrile state. Blut 1990 1.39
35 Administration of recombinant human granulocyte-macrophage colony-stimulating factor to children undergoing allogeneic marrow transplantation: a prospective, randomized, double-masked, placebo-controlled trial. Pediatr Transplant 2000 1.39
36 The first reported outbreak of diarrheal illness associated with Cyclospora in the United States. Ann Intern Med 1995 1.38
37 Focus control system for laser welding. Appl Opt 1997 1.37
38 Towards specific functions of lysosomal cysteine peptidases: phenotypes of mice deficient for cathepsin B or cathepsin L. Biol Chem 2001 1.34
39 Hematopoietic SCT in Europe: data and trends in 2011. Bone Marrow Transplant 2013 1.34
40 Mucopolysaccharidosis VI (Maroteaux-Lamy syndrome): six unique arylsulfatase B gene alleles causing variable disease phenotypes. Am J Hum Genet 1994 1.33
41 Correction of human mucopolysaccharidosis type-VI fibroblasts with recombinant N-acetylgalactosamine-4-sulphatase. Biochem J 1992 1.32
42 Targeted disruption of the M(r) 46,000 mannose 6-phosphate receptor gene in mice results in misrouting of lysosomal proteins. EMBO J 1993 1.31
43 A multi-institutional analysis of laparoscopic orchidopexy. BJU Int 2001 1.30
44 A multi-centre cohort study of the physical health of 5-year-old children conceived after intracytoplasmic sperm injection, in vitro fertilization and natural conception. Hum Reprod 2004 1.28
45 International collaborative study of intracytoplasmic sperm injection-conceived, in vitro fertilization-conceived, and naturally conceived 5-year-old child outcomes: cognitive and motor assessments. Pediatrics 2005 1.27
46 Degradation of mouse invariant chain: roles of cathepsins S and D and the influence of major histocompatibility complex polymorphism. J Exp Med 1997 1.25
47 Monitoring of adenovirus load in stool by real-time PCR permits early detection of impending invasive infection in patients after allogeneic stem cell transplantation. Leukemia 2010 1.25
48 Potential role for cathepsin D in p53-dependent tumor suppression and chemosensitivity. Oncogene 1998 1.22
49 Regulation of megakaryocyte phenotype in human erythroleukemia cells. J Clin Invest 1990 1.20
50 Transgenic expression of human cathepsin B promotes progression and metastasis of polyoma-middle-T-induced breast cancer in mice. Oncogene 2010 1.19
51 Subcutaneous sumatriptan in the treatment of headache during withdrawal from drug-induced headache. Headache 1991 1.18
52 Randomized phase III study of granulocyte transfusions in neutropenic patients. Bone Marrow Transplant 2008 1.18
53 Cytokines in the induction and expression of T-cell-mediated granuloma formation and protection in the murine model of listeriosis. Immunol Rev 1997 1.16
54 Mucopolysaccharidosis VI (Maroteaux-Lamy syndrome). An intermediate clinical phenotype caused by substitution of valine for glycine at position 137 of arylsulfatase B. J Biol Chem 1991 1.13
55 Involvement of nitric oxide released from microglia-macrophages in pathological changes of cathepsin D-deficient mice. J Neurosci 2001 1.10
56 Targeted disruption of the arylsulfatase B gene results in mice resembling the phenotype of mucopolysaccharidosis VI. Proc Natl Acad Sci U S A 1996 1.10
57 Ceramide as an activator lipid of cathepsin D. Adv Exp Med Biol 2000 1.08
58 The internalization signal in the cytoplasmic tail of lysosomal acid phosphatase consists of the hexapeptide PGYRHV. EMBO J 1992 1.08
59 Myeloablative radiochemotherapy and hematopoietic stem-cell rescue in poor-prognosis Ewing's sarcoma. J Clin Oncol 1993 1.07
60 Haematopoietic stem cell transplantation trends in children over the last three decades: a survey by the paediatric diseases working party of the European Group for Blood and Marrow Transplantation. Bone Marrow Transplant 2007 1.05
61 Protective immunity and granuloma formation are mediated by two distinct tumor necrosis factor alpha- and gamma interferon-dependent T cell-phagocyte interactions in murine listeriosis: dissociation on the basis of phagocyte adhesion mechanisms. Infect Immun 1992 1.05
62 Infrequent mutation of the WT1 gene in 77 Wilms' Tumors. Hum Mutat 1994 1.05
63 Impact of megatherapy in children with high-risk Ewing's tumours in complete remission: a report from the EBMT Solid Tumour Registry. Bone Marrow Transplant 1995 1.04
64 HIV infection--induced posttranslational modification of T cell signaling molecules associated with disease progression. J Clin Invest 1996 1.02
65 Amyloidogenic processing of human amyloid precursor protein in hippocampal neurons devoid of cathepsin D. J Biol Chem 1996 1.02
66 Short report: gastric infection by Strongyloides stercoralis. Am J Trop Med Hyg 1994 1.01
67 Induction death and treatment-related mortality in first remission of children with acute lymphoblastic leukemia: a population-based analysis of the Austrian Berlin-Frankfurt-Münster study group. Leukemia 2009 1.01
68 Identification, expression, and biochemical characterization of N-acetylgalactosamine-4-sulfatase mutations and relationship with clinical phenotype in MPS-VI patients. Am J Hum Genet 1996 1.00
69 Globoid cell leukodystrophy: distinguishing early-onset from late-onset disease using a brain MR imaging scoring method. AJNR Am J Neuroradiol 1999 1.00
70 Erythropoietin pharmacokinetics in premature infants: developmental, nonlinearity, and treatment effects. J Appl Physiol (1985) 1996 1.00
71 Pre-emptive treatment of CMV DNAemia in paediatric stem cell transplantation: the impact of recipient and donor CMV serostatus on the incidence of CMV disease and CMV-related mortality. Bone Marrow Transplant 2003 1.00
72 Do patients with metastatic and recurrent rhabdomyosarcoma benefit from high-dose therapy with hematopoietic rescue? Report of the German/Austrian Pediatric Bone Marrow Transplantation Group. Bone Marrow Transplant 1997 1.00
73 Juvenile form of mucopolysaccharidosis VI (Maroteaux-Lamy syndrome). A C-terminal extension causes instability but increases catalytic efficiency of arylsulfatase B. J Biol Chem 1994 0.99
74 Mice deficient in lysosomal acid phosphatase develop lysosomal storage in the kidney and central nervous system. J Biol Chem 1997 0.99
75 Field investigations of an outbreak of Ebola hemorrhagic fever, Kikwit, Democratic Republic of the Congo, 1995: arthropod studies. J Infect Dis 1999 0.98
76 Long-term results of local recurrence after breast conservation treatment for invasive breast cancer. Int J Radiat Oncol Biol Phys 2001 0.98
77 Kinetics of chimerism during the early post-transplant period in pediatric patients with malignant and non-malignant hematologic disorders: implications for timely detection of engraftment, graft failure and rejection. Leukemia 1999 0.97
78 Pre-transplant risk factors affecting outcome in Hurler syndrome. Bone Marrow Transplant 2009 0.97
79 Deficiency for the cysteine protease cathepsin L promotes tumor progression in mouse epidermis. Oncogene 2009 0.97
80 Rapid discrimination of early CD34+ myeloid progenitors using CD45-RA analysis. Blood 1993 0.96
81 Phylogenetic conservation of cysteine proteinases. Cloning and expression of a cDNA coding for human cathepsin S. J Biol Chem 1992 0.96
82 Allogeneic bone marrow transplantation for chronic myelomonocytic leukemia in childhood: a report from the European Working Group on Myelodysplastic Syndrome in Childhood. J Clin Oncol 1997 0.96
83 Hydrocele of the spermatic cord: embryology and ultrasonographic appearance. Pediatr Radiol 1996 0.95
84 Impact of pretransplant minimal residual disease after cord blood transplantation for childhood acute lymphoblastic leukemia in remission: an Eurocord, PDWP-EBMT analysis. Leukemia 2012 0.94
85 High spontaneous IL-10 production in unrelated bone marrow transplant recipients is associated with fewer transplant-related complications and early deaths. Bone Marrow Transplant 1999 0.94
86 Lysosomal acid phosphatase is not involved in the dephosphorylation of mannose 6-phosphate containing lysosomal proteins. Eur J Cell Biol 1992 0.94
87 Lysosomal acid phosphatase is internalized via clathrin-coated pits. Eur J Cell Biol 1992 0.94
88 Maternal ECG removal from non-invasive fetal ECG recordings. Conf Proc IEEE Eng Med Biol Soc 2006 0.93
89 Correction of odontoid dysplasia following bone-marrow transplantation and engraftment (in Hurler syndrome MPS 1H). Pediatr Radiol 2000 0.93
90 Outcome of second hematopoietic cell transplantation in Hurler syndrome. Bone Marrow Transplant 2002 0.93
91 An N-acetylgalactosamine-4-sulfatase mutation (delta G238) results in a severe Maroteaux-Lamy phenotype. Hum Mutat 1992 0.93
92 Treosulfan-based preparative regimens for allo-HSCT in childhood hematological malignancies: a retrospective study on behalf of the EBMT pediatric diseases working party. Bone Marrow Transplant 2011 0.93
93 Reconstruction of the immune system after unrelated or partially matched T-cell-depleted bone marrow transplantation in children: immunophenotypic analysis and factors affecting the speed of recovery. Blood 1996 0.92
94 Early recipient chimerism testing in the T- and NK-cell lineages for risk assessment of graft rejection in pediatric patients undergoing allogeneic stem cell transplantation. Leukemia 2011 0.92
95 Conventional vs. liposomal amphotericin B in immunosuppressed children. Pediatr Hematol Oncol 1992 0.92
96 Expression of PRL-1 nuclear PTPase is associated with proliferation in liver but with differentiation in intestine. Am J Physiol 1996 0.91
97 Relapsing tubulointerstitial nephritis in an adolescent with inflammatory bowel disease without aminosalicylate exposure. Clin Nephrol 2010 0.91
98 Functional and metabolic properties of human asialofibrinogen. J Lab Clin Med 1977 0.91
99 Analysis of factors affecting development of carpal tunnel syndrome in patients with Hurler syndrome after hematopoietic cell transplantation. Bone Marrow Transplant 2007 0.91
100 Three-dimensional reconstruction of the dynactin complex by single-particle image analysis. Proc Natl Acad Sci U S A 2005 0.90
101 Structure of the human arylsulfatase B gene. Biol Chem Hoppe Seyler 1993 0.90
102 Affirming the decisions adolescents make about life and death. Hastings Cent Rep 1998 0.90
103 Psychosocial adjustment of pediatric patients after allogeneic stem cell transplantation. Bone Marrow Transplant 1999 0.90
104 Diagnosis of invasive fungal infections by a real-time panfungal PCR assay in immunocompromised pediatric patients. Leukemia 2010 0.90
105 Successful stem cell transplantation following orthotopic liver transplantation from the same haploidentical family donor in a girl with hemophagocytic lymphohistiocytosis. Blood 2000 0.90
106 Cathepsin S regulates the expression of cathepsin L and the turnover of gamma-interferon-inducible lysosomal thiol reductase in B lymphocytes. J Biol Chem 2001 0.90
107 Soft tissue reactions of different biodegradable polylactide implants. Biomaterials 2004 0.90
108 Allogeneic bone marrow transplantation for childhood acute lymphoblastic leukemia in second remission after intensive primary and relapse therapy according to the BFM- and CoALL-protocols: results of the German Cooperative Study. Blood 1991 0.89
109 Four novel mutant alleles of the arylsulfatase B gene in two patients with intermediate form of mucopolysaccharidosis VI (Maroteaux-Lamy syndrome). Hum Genet 1994 0.89
110 Hematopoietic stem cell transplantation for advanced myelodysplastic syndrome in children: results of the EWOG-MDS 98 study. Leukemia 2011 0.88
111 No improvement of survival with reduced- versus high-intensity conditioning for allogeneic stem cell transplants in Ewing tumor patients. Ann Oncol 2011 0.88
112 Two site-directed mutations abrogate enzyme activity but have different effects on the conformation and cellular content of the N-acetylgalactosamine 4-sulphatase protein. Biochem J 1995 0.88
113 Tolerance of granulocyte donors towards granulocyte colony-stimulating factor stimulation and of patients towards granulocyte transfusions: results of a multicentre study. Vox Sang 2003 0.88
114 Murine and human cathepsin Z: cDNA-cloning, characterization of the genes and chromosomal localization. Biochim Biophys Acta 2000 0.87
115 Preclinical safety profile of sildenafil. Int J Impot Res 2004 0.87
116 New roles for glial cell line-derived neurotrophic factor and neurturin: involvement in hair cycle control. Am J Pathol 2000 0.87
117 Organ toxicity and quality of life after allogeneic bone marrow transplantation in pediatric patients: a single centre retrospective analysis. Bone Marrow Transplant 1999 0.87
118 Lineage-specific chimaerism after stem cell transplantation in children following reduced intensity conditioning: potential predictive value of NK cell chimaerism for late graft rejection. Leukemia 2003 0.86
119 Continued neurocognitive development and prevention of cardiopulmonary complications after successful BMT for I-cell disease: a long-term follow-up report. Bone Marrow Transplant 2003 0.86
120 Kinetic evaluation of nonlinear drug elimination by a disposition decomposition analysis. Application to the analysis of the nonlinear elimination kinetics of erythropoietin in adult humans. J Pharm Sci 1995 0.85
121 Relapse, not regimen-related toxicity, was the major cause of treatment failure in 11 children with Down syndrome undergoing haematopoietic stem cell transplantation for acute leukaemia. Bone Marrow Transplant 2007 0.85
122 Spinal cord contains neurotrophic activity for spinal nerve sensory neurons. Late developmental appearance of a survival factor distinct from nerve growth factor. Neuroscience 1984 0.85
123 Restoration of arylsulphatase A activity in human-metachromatic-leucodystrophy fibroblasts via retroviral-vector-mediated gene transfer. Biochem J 1991 0.85
124 Genu valgum deformity in Hurler syndrome after hematopoietic stem cell transplantation: correction by surgical intervention. J Pediatr Orthop 1999 0.85
125 Delayed type hypersensitivity-associated disruption of splenic periarteriolar lymphatic sheaths coincides with temporary loss of IFN-gamma production and impaired eradication of bacteria in Brucella abortus-infected mice. Microbes Infect 2003 0.85
126 Allo-SCT using BU, CY and melphalan for children with AML in second CR. Bone Marrow Transplant 2012 0.85
127 Pulmonary cytolytic thrombi: a newly recognized complication of stem cell transplantation. Bone Marrow Transplant 2000 0.84
128 Immune thrombocytopenia and elemental mercury poisoning. J Toxicol Clin Toxicol 1995 0.84
129 Observing proteases in living cells. Adv Exp Med Biol 2000 0.84
130 Hematopoietic stem cell transplantation for mucopolysaccharidoses and leukodystrophies. Klin Padiatr 2004 0.84
131 Patient and graft survival in amputated versus nonamputated diabetic primary renal allograft recipients. Transplantation 1981 0.84
132 Association analysis of exonic variants of the gene encoding the GABAB receptor and idiopathic generalized epilepsy. Am J Med Genet 1999 0.83
133 Neuropsychological development in children with Hurler syndrome following hematopoietic stem cell transplantation. Pediatr Transplant 1998 0.83
134 Successful bone marrow transplantation in a boy with X-linked lymphoproliferative syndrome and acute severe infectious mononucleosis. Bone Marrow Transplant 1994 0.83
135 Hurler syndrome: past, present, and future. J Pediatr 1998 0.83
136 Heat-shock protein 70-dependent dendritic cell activation by 5-aminolevulinic acid-mediated photodynamic treatment of human glioblastoma spheroids in vitro. Br J Cancer 2011 0.82
137 The genes of the lysosomal cysteine proteinases cathepsin B, H, L, and S map to different mouse chromosomes. Mamm Genome 1997 0.82
138 Bone marrow transplantation during fulminant EBV-infection in Duncan's syndrome. Lancet 1993 0.82
139 In vivo 125I-erythropoietin pharmacokinetics are unchanged after anesthesia, nephrectomy and hepatectomy in sheep. J Pharmacol Exp Ther 1996 0.82
140 Exhaled nitric oxide and pulmonary complications after paediatric stem cell transplantation. Eur J Pediatr 2012 0.82
141 Improved relapse free survival in patients with poor prognosis Ewing's sarcoma after consolidation with hyperfractionated total body irradiation and fractionated high dose melphalan followed by high dose etoposide and hematopoietic rescue. Bone Marrow Transplant 1991 0.82
142 Ferritin concentrations correlate to outcome of hematopoietic stem cell transplantation but do not serve as biomarker of graft-versus-host disease. Ann Hematol 2013 0.82
143 Allogeneic stem cell transplantation for pediatric and adolescent patients with CML: results from the prospective trial CML-paed I. Klin Padiatr 2009 0.82
144 Allogeneic stem cell transplantation for patients with advanced rhabdomyosarcoma: a retrospective assessment. Br J Cancer 2013 0.82
145 Genetic predictors of cardiovascular morbidity in Bardet-Biedl syndrome. Clin Genet 2014 0.81
146 Analysis of chimerism within specific leukocyte subsets for detection of residual or recurrent leukemia in pediatric patients after allogeneic stem cell transplantation. Leukemia 2001 0.81
147 CMV-viraemia during allogenic bone marrow transplantation in paediatric patients: association with survival and graft-versus-host disease. Bone Marrow Transplant 1998 0.81
148 Testosterone secretion by rat, rabbit, guinea pig, dog, and hamster testes perfused in vitro: correlation with Leydig cell mass. Endocrinology 1979 0.81
149 Association analysis of exonic variants of the gene encoding the GABAB receptor and alcohol dependence. Psychiatr Genet 1999 0.81
150 Studies on calorie to nitrogen ratio for total parenteral nutrition. Surg Gynecol Obstet 1980 0.81
151 Enteroviral meningoencephalitis in immunocompromised children after matched unrelated donor-bone marrow transplantation. Pediatr Hematol Oncol 2000 0.81
152 Exonic variants of the GABA(B) receptor gene and panic disorder. Psychiatr Genet 2000 0.81
153 Amphotericin B serum levels in pediatric bone marrow transplant recipients. Bone Marrow Transplant 1991 0.81
154 Ergotamine, flunarizine and sumatriptan do not change cerebral blood flow velocity in normal subjects and migraneurs. J Neurol 1991 0.80
155 Paternity testing with oligonucleotide multilocus probe (CAC)5/(GTG)5: a multicenter study. Forensic Sci Int 1993 0.79
156 Two novel frameshift mutations causing premature stop codons in a patient with the severe form of Maroteaux-Lamy syndrome. Hum Mutat 1996 0.79
157 Cathepsin J, a novel murine cysteine protease of the papain family with a placenta-restricted expression. FEBS Lett 1999 0.79
158 Risks versus benefits of contrast medium exposure in renal allograft recipients. Surg Gynecol Obstet 1983 0.79
159 High-dose melphalan, etoposide +/- carboplatin (MEC) combined with 12-gray fractionated total-body irradiation in children with generalized solid tumors. Pediatr Hematol Oncol 1991 0.79
160 Lymphoproliferative disorder presenting as pulmonary nodules after bone marrow transplantation. Bone Marrow Transplant 2001 0.79
161 Etoposide in combination with cyclophosphamide and total body irradiation or busulfan as conditioning for marrow transplantation in adults and children. Int J Radiat Oncol Biol Phys 1994 0.79
162 Proteolysis of IGFBPs by cathepsin D in vitro and in cathepsin D-deficient mice. Prog Growth Factor Res 1995 0.79
163 Mouse cathepsin D gene: molecular organization, characterization of the promoter, and chromosomal localization. DNA Cell Biol 1994 0.78
164 Effect of retinoic acid on wound healing of laser burns to porcine retinal pigment epithelium. Can J Ophthalmol 1996 0.78
165 Formative and effectiveness evaluation of a worksite program promoting healthy alcohol consumption. Am J Health Promot 1994 0.78
166 Survey on haematopoietic stem cell transplantation for children in Europe. Bone Marrow Transplant 2005 0.78
167 The chemical biology of Ras lipidation. Biol Chem 2001 0.78
168 Strategies of the donor search for children with second CR ALL lacking a matched sibling donor. Bone Marrow Transplant 2008 0.78
169 Resolution of early cytomegalovirus (CMV) infection after leukocyte transfusion therapy from a CMV seropositive donor. Bone Marrow Transplant 1998 0.78
170 Glutathione S-transferase gene variations influence BU pharmacokinetics and outcome of hematopoietic SCT in pediatric patients. Bone Marrow Transplant 2013 0.78
171 Ten-year experience with the artificial urinary sphincter in children. J Urol 1996 0.78
172 Variations in practice among urologists and nephrologists treating children with vesicoureteral reflux. J Urol 1992 0.78
173 A qualitative investigation of organizational issues in an alcohol awareness program for blue-collar workers. Am J Health Promot 1994 0.78
174 The median rise of leucocytes predicts the optimal days for leukapheresis in children. Bone Marrow Transplant 1990 0.78
175 Measurements from normal umbilical cord blood of four lysosomal enzymatic activities: alpha-L-iduronidase (Hurler), galactocerebrosidase (globoid cell leukodystrophy), arylsulfatase A (metachromatic leukodystrophy), arylsulfatase B (Maroteaux-Lamy). Bone Marrow Transplant 2000 0.78
176 Postfertilization poly(A) . protein complex formation on sea urchin maternal messenger RNA. Differentiation 1978 0.77
177 Gastrointestinal perforations in renal transplant recipients immunosuppressed with cyclosporin. World J Surg 1986 0.77
178 Continuous sulfa prophylaxis for urinary tract infection in renal transplant recipients. Am J Surg 1983 0.77
179 Association between glomerular filtration rate and extracellular fluid volume in normal subjects and patients with renal impairment. Scand J Clin Lab Invest 2008 0.77
180 T-cell precursor frequencies and long-term outcome following unrelated hematopoietic stem cell transplantation. Int J Lab Hematol 2008 0.77
181 Viral haemorrhagic fever in Sweden: experiences from management of a case. Scand J Infect Dis 1991 0.77
182 Mouse cathepsin F: cDNA cloning, genomic organization and chromosomal assignment of the gene. Gene 2000 0.77
183 G-CSF versus GM-CSF for stimulation of peripheral blood progenitor cells (PBPC) and leukocytes in healthy volunteers: comparison of efficacy and tolerability. Ann Hematol 1999 0.77
184 Listeriolysin--a useful cytolysin. Trends Microbiol 2001 0.77
185 Role of allogeneic bone marrow transplantation for the treatment of myelodysplastic syndromes in childhood. The European Working Group on Childhood Myelodysplastic Syndrome (EWOG-MDS) and the Austria-Germany-Italy (AGI) Bone Marrow Transplantation Registry. Bone Marrow Transplant 1996 0.77
186 Allogeneic bone marrow transplantation for juvenile myelomonocytic leukaemia: a single centre experience and review of the literature. Bone Marrow Transplant 2000 0.77
187 Treatment of infant leukemia with busulfan, cyclophosphamide +/- etoposide and bone marrow transplantation. Bone Marrow Transplant 1992 0.77
188 Paternal sperm concentration and growth and cognitive development in children born with a gestational age more than 32 weeks after assisted reproductive therapy. Hum Reprod 2006 0.77
189 Oral busulfan pharmacokinetics and engraftment in children with Hurler syndrome and other inherited metabolic storage diseases undergoing hematopoietic cell transplantation. Bone Marrow Transplant 2001 0.77
190 Inotropic, vascular and neuroendocrine effects of dopexamine hydrochloride and comparison with dobutamine. Am J Cardiol 1988 0.77
191 Flow cytometric monitoring of hematopoietic reconstitution in myeloablated patients following allogeneic transplantation. Cytotherapy 1999 0.77
192 Reconstruction of the immune system after unrelated or partially matched T-cell-depleted bone marrow transplantation in children: functional analyses of lymphocytes and correlation with immunophenotypic recovery following transplantation. Clin Diagn Lab Immunol 1997 0.77
193 T-cell-depleted peripheral blood stem cell transplantation for alpha-mannosidosis. Bone Marrow Transplant 2003 0.76
194 Growth-dependent regulation of cellular ceramides in human T-cells. Biochim Biophys Acta 1994 0.76
195 Upper extremity radionuclide venography in the diagnosis and management of venous disease associated with intravenous catheters. Angiology 1988 0.76
196 Serial granulocytapheresisunder daily administration of rHuG-CSF: effects on peripheral blood counts, collection efficiency, and yield. Transfusion 2001 0.76
197 Human leukocyte antigen distribution in German Caucasians with advanced Ewing's sarcoma. Klin Padiatr 2012 0.76
198 Long-term remission in pediatric Wegener granulomatosis following allo-SCT after reduced-intensity conditioning. Bone Marrow Transplant 2010 0.76
199 Phosphate ester groups in proteoglycans from bovine nasal cartilage. Biochim Biophys Acta 1981 0.76
200 Influence of fractionated total body irradiation on mucosal toxicity in intensified conditioning regimens for autologous bone marrow transplantation in pediatric cancer patients. Klin Padiatr 1994 0.76
201 Combined anti-fungal therapy and surgical resection as treatment of disseminated aspergillosis of the lung and brain following BMT. Bone Marrow Transplant 1993 0.76
202 Is treatment intensification by adding etoposide and carboplatin to fractionated total body irradiation and melphalan acceptable in children with solid tumors with respect to toxicity? Bone Marrow Transplant 1991 0.76
203 Isolated extramedullary relapse in children with acute lymphoblastic leukemia: a comparison between treatment results of chemotherapy and bone marrow transplantation. BFM Relapse Study Group. Bone Marrow Transplant 1995 0.76
204 Pharmacokinetics and pharmacodynamics of erythropoietin during therapy in an infant with renal failure. J Pediatr 1992 0.76
205 Transplantation of related and unrelated umbilical cord blood stem cells in Austria. Austrian Working Party for Stem Cell Transplantation. Austrian Society of Hematology and Oncology. Wien Klin Wochenschr 1999 0.75
206 Influence of immunosuppression on acute liver toxicity after intensified conditioning regimens for bone marrow transplantation in children. Blood 1991 0.75
207 Secondary graft failure associated with parainfluenza virus infection following hematopoietic cell transplantation. Bone Marrow Transplant 2005 0.75
208 Can long-term antidepressant use be depressogenic? J Clin Psychiatry 1999 0.75
209 The pharmacokinetics of caudal ropivacaine 0.2% in children. A study of infants aged less than 1 year and toddlers aged 1-5 years undergoing inguinal hernia repair. Anaesthesia 2000 0.75
210 Measurement of CP-violating asymmetries in B0 decays to CP eigenstates. Phys Rev Lett 2001 0.75
211 Rhinoplasty. Plast Surg Nurs 1989 0.75
212 Interview. Chris Peters talks to Catalina Hinchey Trujillo, about her work for the UN agency Habitat. Gend Dev 1996 0.75
213 The development of an obstetric tele-monitoring system. Conf Proc IEEE Eng Med Biol Soc 2015 0.75
214 Effect of retinoic acid on expression of transforming growth factor-beta by retinal pigment epithelial cells in culture. Can J Ophthalmol 1995 0.75
215 [Collection and long-term preservation of peripheral stem cells]. Beitr Infusionsther 1993 0.75
216 Unrelated-donor bone marrow transplantation for Philadelphia chromosome-positive chronic myelogenous leukemia in children: experience of eight European Countries. The EBMT Paediatric Diseases Working Party. Bone Marrow Transplant 1996 0.75
217 [Autologous bone marrow transplantation in children with acute leukemia or non-Hodgkin's lymphoma]. Wien Med Wochenschr 1991 0.75
218 Standards of stem cell transplantation: Part I: the accreditation of paediatric stem cell transplantation centres within the EBMT; Part II: intensive care units in paediatric stem cell transplantation; Part III: informed consent and sibling donor issues. Bone Marrow Transplant 2001 0.75
219 [Autologous peripheral stem cell transplantation in children]. Klin Padiatr 1989 0.75
220 Coagulation factor XIII in plasma of patients with benign and malignant gynaecological tumours. Eur J Clin Chem Clin Biochem 1994 0.75
221 Cytomegalovirus encephalitis resistant to anti-cytomegalovirus therapy. AIDS 1995 0.75
222 Nursing care study: tuberous sclerosis. Nurs Times 1973 0.75
223 Peripheral blood hematopoietic progenitor cells of cytokine-stimulated healthy donors as an alternative for allogeneic transplantation. Blood 1994 0.75
224 The gene encoding the alpha1A-voltage-dependent calcium channel (CACN1A4) is not a candidate for causing common subtypes of idiopathic generalized epilepsy. Epilepsy Res 1998 0.75
225 The present role of bone marrow and stem cell transplantation in the therapy of children with acute leukemia. Ann N Y Acad Sci 1997 0.75
226 BMT from unrelated (UD) or family donors other than HLA identical siblings (FDNS), GVHD prophylaxis, incidence and treatment. Bone Marrow Transplant 1996 0.75
227 Antidepressant treatment and neural plasticity. J Child Adolesc Psychopharmacol 2000 0.75
228 Polypeptide composition of the globin poly(A)-protein complex from rabbit reticulocytes. Mol Biol Rep 1977 0.75
229 [Adaptive methods in description and comparison of the distribution of biological signals]. Biomed Tech (Berl) 1997 0.75
230 Acute stroke unit improves stroke management-four years on from INASC. Ir Med J 2015 0.75
231 Upper airway complications in children after bone marrow transplantation. Laryngoscope 2000 0.75
232 A single centre experience with allogeneic stem cell transplantation for severe aplastic anaemia in childhood. Klin Padiatr 1997 0.75
233 Prolongation of allograft survival by cyclosporin A. Surg Forum 1979 0.75
234 Ovine and Human Placental IgG inhibit Human Natural Killer Cell Cytotoxicity in vitro. Afr J Health Sci 2007 0.75
235 Influence of transplantation regimen on prognostic significance of high-level minimal residual disease before allogeneic stem cell transplantation in children with ALL. Bone Marrow Transplant 2001 0.75
236 Treatment of severe aplastic anemia with a prolonged course of anti-thymocyte globulin. Transplant Proc 1982 0.75
237 Real-time, nonintrusive oxidation detection system for the welding of reactive aerospace materials. Appl Opt 2001 0.75
238 [Therapeutic concept in combined orthodontic-surgical treatment of class II malocclusion with short face syndrome. New aspects for surgical lengthening of the lower face]. Mund Kiefer Gesichtschir 2000 0.75
239 Reliability of the MDRD method for estimating glomerular filtration rate in relation to gender, body mass index and extracellular fluid volume. Eur J Clin Invest 2008 0.75
240 Non-atopic IgE and eosinophil cationic protein after allogeneic hematopoietic stem cell transplantation in children. Ann Hematol 2012 0.75
241 Humanistic medicine: knowing the person as well as the disease. New Physician 1979 0.75
242 NICU redesign from open ward to private room: a longitudinal study of parent and staff perceptions. J Perinatol 2013 0.75
243 Imidovanadium(v) complexes as reaction partners for kinetically stabilized phosphaalkynes: synthesis of 1,2,4-azaphosphavanada(v)-cyclobutenes, 1,3,5-triphosphabenzenes, and 1H-1,2,4-azadiphospholes. Chemistry 2000 0.75
244 Humanistic medicine: what is health for? New Physician 1979 0.75
245 Family participation unit. Am J Nurs 1968 0.75
246 Molecular organization, expression and chromosomal localization of the mouse pronapsin gene. Eur J Biochem 2000 0.75
247 Public, not doctors, should control health care. Dent Dimens 1977 0.75
248 Development of aplastic anemia and the exposure to Stoddard solvent. Blood 1970 0.75
249 Teenage pregnancy prevention. J Health Care Poor Underserved 1991 0.75
250 [Macroscopic pathologic anatomy technicians. Function and recrutment in the Hospital Center]. Ann Anat Pathol (Paris) 1978 0.75
251 James--nearer to independence. Nurs Times 1973 0.75
252 Extramedullary relapse despite graft-versus-leukemia effect after bone marrow transplantation in a girl with juvenile myelomonocytic leukemia. Leuk Lymphoma 1999 0.75
253 Limited tolerance of intensified conditioning regimens in children receiving methotrexate/cyclosporin A for graft-versus-host disease prophylaxis. Pediatr Hematol Oncol 1992 0.75
254 [Use in histological technic of naphtol AS-D chloroacetate for demonstration of granulocyte series elements]. Ann Anat Pathol (Paris) 1978 0.75
255 Stem cell procurement and transplantation in paediatric patients. Transfus Sci 1994 0.75
256 Augmented environments for minimally invasive therapy: implementation barriers from technology to practice. Stud Health Technol Inform 2012 0.75
257 A cancer patient and his family face the future. Can Fam Physician 1985 0.75
258 Mouse procathepsin E gene: molecular organisation and chromosomal localisation. Biochim Biophys Acta 1998 0.75
259 Proceedings of the 6th Meeting of the EBMT Paediatric Diseases Working Party and 1st Meeting of the EBMT Paediatric Nurses. Introduction. Bone Marrow Transplant 2008 0.75
260 Remote telemetry: new twists for old technology. Nurs Manage 1995 0.75
261 Haemostasis activation markers in plasma of patients with benign and malignant gynaecological tumours: a pilot study. Eur J Clin Chem Clin Biochem 1995 0.75
262 Lemierre syndrome in a 19-year-old man with acute swollen neck. JBR-BTR 2008 0.75
263 Iowa newborn hemoglobinopathy screening and comprehensive care: a model for rural states. J Pediatr Hematol Oncol 1996 0.75
264 Bronchial obstruction treated by fibreoptic-guided suction. Eur J Anaesthesiol 2002 0.75
265 Report of severe neurotoxicity with cyclophosphamide. J Pediatr Hematol Oncol 2000 0.75
266 Oligonucleotide DNA fingerprinting: results of a multi-center study on reliability and validity. EXS 1993 0.75
267 Blepharoplasty. Plast Surg Nurs 1989 0.75
268 High-dose cyclophosphamide, adriamycin, and vincristine (HD-CAV) in children with recurrent solid tumor. Pediatr Hematol Oncol 1995 0.75
269 [Collection and long-term preservation of peripheral stem cells]. Wien Med Wochenschr 1995 0.75
270 High-dose melphalan, etoposide, and carboplatin (MEC) +/- fractionated total body irradiation for treatment of advanced solid tumors. Pediatr Hematol Oncol 1992 0.75
271 Allogeneic bone marrow transplantation-mediated transfer of specific immunity against Toxocara canis associated with excessive IgE. Bone Marrow Transplant 2001 0.75
272 Monitoring genomic alterations with a panel of oligonucleotide probes specific for various simple repeat motifs. Electrophoresis 1991 0.75
273 Transposition of the lips for the correction of facial paralysis. Plast Reconstr Surg 1976 0.75
274 Complete remission of 4 years following autologous blood stem cell transplantation in a child with early relapse of translocation t(9;X) acute lymphoblastic leukemia. Pediatr Hematol Oncol 1992 0.75
275 [Phenotypic differences between CD34 positive cells in various transplantation tissues]. Klin Padiatr 1995 0.75
276 Remission after 13-cis retinoic acid in thrombotic thrombocytopenic purpura. Lancet 1998 0.75
277 Determining consanguinity by oligonucleotide fingerprinting with (GTG)5/(CAC)5. Electrophoresis 1991 0.75